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Abstract 
Silver nanoparticles are one of the most important materials in the nanotechnology industry. Additionally, the protein 
corona is emerging as a key entity at the nanobiointerface; thus, a comprehensive understanding of the interactions 
between proteins and silver nanoparticles is imperative. Therefore, literature reporting studies involving both single 
molecule protein coronas (i.e., bovine and human serum albumin, tubulin, ubiquitin and hyaluronic-binding protein) 
and complex protein coronas (i.e., fetal bovine serum and yeast extract proteins) were selected to demonstrate the 
effects of protein coronas on silver nanoparticle cytotoxicity and antimicrobial activity. There is evidence that distinct 
and differential protein components may yield a “protein corona signature” that is related to the size and/or surface 
curvature of the silver nanoparticles. Therefore, the formation of silver nanoparticle protein coronas together with 
the biological response to these coronas (i.e., oxidative stress, inflammation and cytotoxicity) as well as other cellular 
biophysicochemical mechanisms (i.e., endocytosis, biotransformation and biodistribution) will be important for nano-
medicine and nanotoxicology. Researchers may benefit from the information contained herein to improve biotech-
nological applications of silver nanoparticles and to address related safety concerns. In summary, the main aim of this 
mini-review is to highlight the relationship between the formation of silver nanoparticle protein coronas and toxicity.
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Background
Recently, silver nanoparticles have received a great deal 
of attention because of their distinctive physicochemical 
and biological properties. This interest originated with 
the use of silver nanoparticles in many different products 
because of their exceptionally small size and their poten-
tial antibacterial effect [1–3]. Currently, silver nanopar-
ticles are primarily used for catalysis, transport, sensing 
and many other biological and medical applications [4, 
5]. However, these applications have increased the pos-
sibility of living organisms being directly or indirectly 
exposed to silver nanoparticles, which could induce 
numerous deleterious effects on human health and the 
environment. The adverse effects (primary or second-
ary) of silver nanoparticles on organs can extend into the 
cardiovascular or central nervous system, thereby caus-
ing neurotoxicity or immunotoxicity [6, 7].
Important aspects of interactions between silver 
nanoparticle and cellular systems
The cytotoxicity and genotoxicity of silver nanoparticles 
depends on many factors (e.g., concentration, dispersion, 
size and surface functionalization) [8–11]. For example, 
reports have indicated that the size of silver nanoparti-
cles is an important factor for cytotoxicity and genotox-
icity, probably acting through apoptosis and necrosis 
mechanisms [12, 13]. Exposure of the human body to 
silver nanoparticles can occur through different routes 
(e.g., inhalation, ingestion, injection or physical contact 
with cuts or wounds); caution is necessary because some 
in vitro data suggest that even low concentrations of sil-
ver nanoparticles can be toxic in some cases [14–17]. 
Asharani et  al. [15] showed by transmission electron 
microscopy (TEM) that silver nanoparticles can pene-
trate into cellular compartments such as endosomes, lys-
osomes and mitochondria (Fig. 1).
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Many types of cells that interact with silver nanoparti-
cles have been cultured and studied, including red blood 
cells, BRL3A rat liver cells, PC-12 neuroendocrine cells, 
GSCs germ line stem cells, RBE4 rat brain endothe-
lial cells, MCF-7 human breast adenocarcinoma cells, 
HepG2 human liver cells, BEAS-2B bronchial epithe-
lial cells, A4549 lung alveolar epithelial cells, and hMSC 
human mesenchymal stem cells (Fig. 2) [9, 18–30]. Thus 
far, data collected in  vitro and in  vivo indicate that the 
production of reactive oxygen species (ROS) plays an 
important role in the toxic effects of silver nanoparticles 
[31, 32] and is responsible for many changes (e.g., molec-
ular and biochemical) related to genotoxicity in cul-
tured cells (e.g., DNA breakage) [33]. It is also stated in 
the literature that the dissolution of silver nanoparticles 
may have a key role in their toxicity [34, 35]. Moreover, 
many studies have suggested that the antimicrobial activ-
ity of silver nanoparticles on different types of pathogens 
depends on oxidative stress [36–39].
Knowledge of the chronic toxic effects that result 
from low-level exposure to silver nanoparticles is lim-
ited. A study of 10 nm silver, iron and gold nanoparticles 
demonstrated that all particles impeded epidermal 
growth factor (EGF)-dependent signal transduction, but 
by different mechanisms, as shown in Fig. 3. Silver nano-
particles produced a high ROS level and diminished ser-
ine/threonine protein kinase (Akt) and small guanosine 
triphosphate-binding protein/extracellular signal-regu-
lated kinase (Erk) signaling. Silver nanoparticles signifi-
cantly diminished the phosphorylation of Akt and Erk 
and inhibited Akt activity. Comfort et al. [36] stated that 
pretreatment with these metallic nanoparticles drasti-
cally interfered with the cellular response to EGF. Moreo-
ver, they reported that the major challenge is to be able to 
correlate the data obtained using an in vitro model and 
extrapolate the results to an in vivo system.
In an industrial environment, the most relevant occu-
pational health risk from exposure to silver nanoparticles 
is inhalational; therefore, an important study was carried 
out with the A549 cell line, which is widely used as an 
in vitro model of pulmonary epithelial cells for nanotox-
icity studies [40]. The authors found that the toxicity of 
silver nanoparticles to these cells were mediated via ROS-
dependent and also ROS-independent pathways [40].
Fig. 1 TEM images of ultrathin sections of cells. Untreated cells showed no abnormalities (a), whereas cells treated with silver nanoparticles showed 
large endosomes near the cell membrane with many nanoparticles inside (b). Electron micrographs showing lysosomes with nanoparticles inside 
(thick arrows) and scattered in cytoplasm (open arrow). Diamond arrow shows the presence of the nanoparticle in the nucleus (c). Magnified images 
of nanogroups showed that the cluster is composed of individual nanoparticles rather than clumps (d). Image shows endosomes in cytosol that are 
lodged in the nuclear membrane invaginations (e) and the presence of nanoparticles in mitochondria and on the nuclear membrane (f) (repro-
duced from ref. Asharani et al. [14]. by permission of American Chemical Society)
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When investigating the biological activities of silver 
nanoparticles, it is important to recognize that the nano-
particles will always interact with a protein medium, such 
as cell culture medium or a bacterial culture, prior to 
their biological actions. Therefore, the presence of a pro-
tein corona could make a vast difference to their biologi-
cal activity. Consequently, it is important to review these 
topics and how they relate specifically to the interactions 
of silver nanoparticles with biological systems because 
this nanomaterial is exceedingly important in the market 
[6, 41].
General aspects of protein corona
The corona formation process depends on competi-
tion between proteins to be adsorbed onto the sur-
face of nanoparticles. Miclaus et  al. [42] suggested that 
the nanoparticle-protein interaction is dynamic, with 
exchanges between surface-bound and bulk proteins 
occurring on different time scales. Proteins with higher 
affinity for the surface exchange slowly, forming the hard 
corona, the innermost layer composed of tightly bound 
proteins (over longer periods of hours). Other proteins 
with low affinity are very quickly replaced, forming the 
soft corona, the outer layer composed of loosely bound 
proteins with lower affinity for the nanoparticle surface 
(over short time scales of seconds or minutes) (Fig. 4).
To better understand the interactions between nano-
particles and biological fluids, many studies have been 
performed in vitro and/or in vivo on tissues, on cells [42] 
and especially on proteins [44, 45]. All current data indi-
cate that it is the proteins contained in the corona and 
not the nanoparticles themselves that interact with the 
Fig. 2 Detection of silver nanoparticles after an incubation time of 24 h inside hMSC by FIB/SEM (a, c) and the corresponding elemental analysis 
(b, d). The cells were cultured for 24 h with 50 µg ml−1 silver nanoparticles (c, d) or without Ag-NP (a, b). A part of the gold-sputtered hMSC and the 
surface was cut by ion milling in order to visualize the internalized particles. The EDX spectra (b, d) show the detected elements; the black arrow 
denotes silver within the milled cell (d). The insets in b and d represent the enlarged area denoted by the white frames in Fig. 1a, c (reproduced 
from ref. Greulich et al. [9], by permission of Elsevier Ltd.)
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cells [46, 47]. Therefore, the nanoparticle-corona com-
plex is a new entity that represents “what the cell sees”, 
with the corona being the interface between the nano-
particle and the cellular system [46]. Thus, under physi-
ological conditions, the protein corona that forms on 
the surfaces of nanoparticles determines their biological 
identities [48–54]. It has been suggested that this protein 
corona is more significant in determining the biological 
response (i.e., immunogenicity) than the bare material 
properties of the particle itself [43].
The parameters that affect corona composition include 
particle size [50], particle shape [55] and particle surface 
[56] properties as well as biological fluid properties and 
composition [47]. The formation of both soft and hard 
coronas is an equilibrium process in which the protein 
composition is directed by the initial concentration of 
each protein in the medium as well as its off rate (kback) 
[42]. Corona formation and composition have important 
implications for both toxicity [43] and internalization 
[57].
Many studies have been performed on the long-lived, 
hard corona because it can be separated from the incu-
bation medium through subsequent centrifugation and 
washing steps. However, it is important to note that this 
corona represents the proteins with longer residence 
times than the period of the washing steps in the sepa-
ration process [58]. Recently, Del Pino et  al. [59] deter-
mined that each washing step causes a decrease in the 
bulk biomolecule concentration, which shifts the equi-
librium of bound and unbound proteins and specifically 
removes the faster exchanging fraction [42].
These aspects are all related, in general, to different 
types of nanoparticles. Therefore, the overview herein 
will discuss a more specific topic, silver nanoparticles, 
and what has been published in this important area once 
silver is the most widely used nanostructured material 
with many potential effects in biological systems and 
even on environmental behavior [2, 4, 6, 60–65].
Specific aspects of silver nanoparticle protein 
coronas
Proteins
Bovine serum albumin (BSA)
One of the first papers on protein coronas [51] used the 
structure of the bovine serum albumin (BSA) molecule 
because BSA is an adequate model system for the study 
of nanoparticle/protein interactions. In this study, two 
chemically synthesized silver nanoparticles with either 
a 20 nm diameter (3 × 1014 nm2 mL−1 surface area per 
mL) or a 40  nm diameter (3 ×  1015 nm2  mL−1) capped 
with citrate and 70 nm silver nanoparticles capped with 
polyvinylpyrrolidone (PVP) were incubated with BSA. 
The α-helix content of the protein was analyzed using cir-
cular dichroism spectroscopy, which was based on differ-
ent spectral intensities at 208 and 220 nm. BSA primarily 
contains α-helices as its secondary structural elements, 
and the loss of the structure of this protein shows the 
degree of disruption of interaction between BSA and the 
nanoparticles. The BSA signal decreased with an increase 
in the surface area of citrate-coated silver nanoparti-
cle present in the mixture. The authors showed that the 
nanoparticle surface area required to remove free protein 
from the bulk solution corresponded well to the calcu-
lated amount of protein that could be adsorbed in a mon-
olayer on the surface of the nanoparticles. Compared to 
citrate-stabilized silver nanoparticles, the interaction of 
BSA with PVP-stabilized silver nanoparticles revealed 
a different fate. Although the signal behavior showed 
similar aspects to the spectra run for citrate-coated sil-
ver nanoparticles, a completely different behavior was 
observed as the surface area of the nanoparticles was 
increased. The band at 208  nm decreased significantly 
compared to the second relative minimum at approxi-
mately 220  nm, which was completely different from 
citrate-silver nanoparticles and probably means that the 
mechanistic interpretation is more complex than in the 
case of citrate.
Treuel et  al. [66] demonstrated that the behavior of 
proteins (such as BSA) towards nanoparticles could 
be strongly affected by the presence of polymer coat-
ings, as previously discussed. Surface-enhanced Raman 
Fig. 3 Sites of cellular disruption by metallic nanoparticles. This 
model depicts the different cellular events in which silver (Ag), and 
gold (Au) nanoparticles were found to interfere (reproduced from ref. 
Comfort et al. [34] by permission of American Chemical Society)
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spectroscopy was used for further elucidation of protein 
binding to silver surfaces. The first interpretation of the 
differences in binding affinities for the citrate silver nano-
particles and the PVP silver nanoparticles was that the 
strong interactions between sulfur-containing groups in 
the protein and the metal surface was prevented when 
a polymer coating was present. The authors suggested 
that nanotoxicology might benefit from this information, 
which could be used to improve nanomedicinal applica-
tions. By using a wide range of polymer surface coatings, 
the biological transport and medical action of nanoparti-
cles could be optimized. In the case of multiple-protein 
coronas, simulating real in vivo situations, the competi-
tion between the proteins present the medium is very 
expressive, thus the nanoparticle surface properties 
become even more relevant.
Similar results were published with different meth-
odologies regarding albumin-silver nanoparticle inter-
actions [67, 68]. Podila et  al. [69] investigated the 
physiological and chemical interactions of a simple pro-
tein corona by studying the combination of a specific 
protein, such as BSA, with PVP- and citrate- stabilized 
silver nanoparticles. TEM images (Fig.  5a) confirmed 
that the uncoated silver nanoparticles produced via laser 
ablation (La-silver nanoparticles) were spherical with 
an unimodal diameter distribution (24  nm). The aver-
age diameter of citrate- and PVP-coated silver nanopar-
ticles was approximately 20  nm. In the investigation of 
protein binding, an adequate amount of BSA (0–15 nM) 
was added to the silver nanoparticle suspension (10 µM) 
and thoroughly mixed via stirring to achieve good dis-
persion. Then, the suspensions were incubated at 37  °C 
for 1 h.
It can be observed in Fig. 5c–e that the La-silver nan-
oparticles exhibited more protein coating than the cit-
rate- or PVP-coated silver nanoparticles. Moreover, 
the citrate- and PVP-coated silver nanoparticles aggre-
gated upon exposure to proteins, indicating that their 
Fig. 4 Schematic illustration and characteristics of a hard and a soft corona. The protein corona encompassing the nanoparticles. Hard coronas 
are characterized by slow exchange (i.e., several hours) and lower abundance, with a high affinity of proteins, whereas soft coronas are typified by 
rapid exchange (i.e., several minutes) and lower affinity of proteins with weakly bound outer layers on nanoparticles. There is a different response of 
cellular and biochemical factors by soft and hard corona formation. *Compared with serum-free condition. †Compared with soft corona (modified 
from ref. Lee et al. [41])
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electrostatic stabilization groups were displaced from 
their surfaces.
In agreement with the TEM results (Fig.  5a), the 
dynamic light scattering results indicated that the Laser 
ablation (La)-silver nanoparticles supported the highest 
saturation amount of BSA compared to the citrate-and 
PVP-coated silver nanoparticles (Fig. 5b).
The ratio of the areas under the β-sheets to α-helices 
(I1630/I1650) by FTIR provided a quantitative measure for 
the net change in protein entropy. Native BSA had a ratio 
of <1, indicating an ordered form (higher α-helices). After 
the interaction of BSA with the nanoparticles, the ratios 
were greater than 1 (citrate-silver nanoparticles ~1.5, 
PVP-silver nanoparticles ~2.5 and La-silver nanoparti-
cles ~9.5), indicating that all nanoparticle types induced 
an increase in the protein conformational entropy, or a 
decrease in α-helix content. Additionally, the change in 
conformational entropy was highest for the uncoated La- 
silver nanoparticles, consistent with previously observed 
protein adsorption on bulk surfaces. Finally, the authors 
found that uncoated and surfactant-free silver nanopar-
ticles prepared using a physical process produced maxi-
mal BSA coatings owing to their increased changes in 
entropy. However, BSA exhibited a relatively lower affin-
ity for electrostatically stabilized nanoparticles because it 
exerted constrained entropy changes.
This finding was similar that of Shannahan et al. [70], 
who found that 20 nm silver nanoparticles bound more 
strongly to hydrophobic proteins than did 110  nm sil-
ver nanoparticles. These authors suggested that the 
complexity and abundance of the protein corona con-
stituents, in general, were related to the free energy in 
Fig. 5 a The diameter distribution for laser ablated silver nanoparticles (La-silver nanoparticles) exhibits a unimodal distribution with an average 
24 nm. The inset shows a representative TEM image for La silver nanoparticles. b The hydrodynamic diameter for BSA coated silver nanoparticles 
(BSA-silver nanoparticles) is different for different surface coatings. TEM images for BSA coated citrate coated silver nanoparticles (Citrate-silver 
nanoparticles) (c) and PVP coated silver nanoparticles (PVP-silver nanoparticles) (d) and La-silver nanoparticles (e) show that the coating is maxi-
mum for La silver nanoparticles in agreement with the hydrodynamic diameter. The scale bar for all the panels is 20 nm. (reproduced from ref. Podila 
et al. [67], by permission of American Institute of Physics)
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protein folding-unfolding induced by different surface 
components for silver nanoparticles of the same size. 
However, the differences in protein corona formation for 
20 and 110 nm silver nanoparticles were most likely due 
to their surface curvature and the energy involved in pro-
tein adsorption and agglomeration. In other words, this 
report demonstrated the importance of electrostatic and 
hydrophobic interactions in protein corona formation, 
showing the broad biological and toxicological implica-
tions of these interactions. It is possible to conclude that 
the surface stabilization by different capped materials, a 
different BSA interaction occurred. The comparison of 
bare nanoparticles (laser ablation) versus citrate- or PVP-
coated nanoparticles showed coated silver nanoparticles 
aggregated upon exposure to BSA, indicating that their 
electrostatic stabilization groups were offset from their 
surfaces. Then, BSA exhibited a relatively lower affinity 
for electrostatically stabilized nanoparticles because it 
exerted constrained entropy changes, thus, demonstrat-
ing the importance of electrostatic and hydrophobic 
interactions in protein corona formation from BSA.
Fetal calf and bovine serum
To understand PVP-stabilized silver nanoparticles, sev-
eral protein moieties were studied. PVP-stabilized silver 
nanoparticles agglomerated and precipitated very fast 
in protein-free RPMI cell culture medium, which con-
tains serum proteins [71, 72]. BSA partially prevented 
this agglomeration, but fetal calf serum (FCS) prevented 
the agglomeration entirely. The interaction of these two 
capped silver nanoparticles with FCS showed slight toxic 
effects against human mesenchymal stem cells. The tox-
icity of the silver nanoparticles is probably due to the 
release of silver ions and the BSA and FCS probably bind 
to these ions, thus avoiding their toxicity, although other 
factors can be acting simultaneously. It is also known that 
BSA and silver nanoparticles form complexes by van der 
Waals and electrostatic forces, and these metal ion–albu-
min complexes are easily internalized by cells [73]. It is 
worth to notice that the formation of the corona around 
the silver nanoparticles may also affect their dissolution 
rates, likely affecting their overall toxicity. Therefore, the 
true nature of the protective effect of proteins needs fur-
ther study, and silver nanoparticles must be used with 
care because their agglomeration behavior and the pres-
ence of proteins play important functional roles [71, 72].
To study the bond strength between nanoparticles and 
proteins and the progress of the equilibrium, Casals et al. 
[74] incubated citrate-silver nanoparticles (20  nm) in 
complete cell culture medium (cCCM), which consisted 
of Dulbecco’s modified Eagle’s medium [DMEM-10  % 
fetal bovine serum (FBS)] at a 10 % (v/v) dilution at 37 °C. 
These electrostatically stabilized silver nanoparticles 
were unstable when dispersed in solvents with a high 
ionic strength (e.g., DMEM) but stable when dispersed 
in the same solvents (e.g., DMEM) with 10 % FBS. Then, 
the adsorption/conjugation of proteins on the silver nan-
oparticle surfaces initiated as soon as the nanoparticles 
were dispersed in cCCM, which caused steric repulsion 
to occur more quickly than aggregation. In fact, the sil-
ver nanoparticle diameters were increased by up to twice 
the initial diameter. A simple purification process (cen-
trifugation and resuspension in water) was carried out 
to distinguish the adsorbed protein from the free protein 
in solution. Part of the initial surface charge of the sil-
ver nanoparticles incubated with cCCM was recovered, 
indicating that only certain proteins remained attached 
to their surfaces and reached a stable/irreversible value. 
All data were indicative that the proteins had undergone 
a stabilization process, making them strong enough to 
maintain their final form as a hard protein corona over a 
long period of time in protein-free solutions. The authors 
suggested two steps in this process: (1) conjugation of a 
transient protein corona that forms immediately when 
nanoparticles contact the cCCM, which evolves a stable 
protein corona that remains bound to the nanoparticle 
surface even when the conjugates are taken out of cCCM 
and (2) redispersion in pure water (Scheme 1) [74].
Miclaus et  al. [42] studied the interaction of silver 
nanocubes (synthesized by polyol synthesis and stabi-
lized by PVP) with FBS, confirming the occurrence of 
a dynamic equilibrium process in which soft and hard 
coronas presented different exchange rates for this struc-
ture as well (Fig. 6).
Ashkarran et al. [1] studied soft and hard corona effects, 
investigating the interactions of four different silver nano-
particle structures (cube, sphere, wire and triangle) with 
FBS in situ. SDS-PAGE analysis was conducted to demon-
strate the interaction of the nanoparticles with the proteins 
in this fluid. The authors found that the protein coronas 
had different concentrations and compositions depending 
on the nanoparticle structure, indicating that protein-nan-
oparticle interactions are morphology-dependent (Fig. 7). 
Its is worth to mention that not only the curvature effects 
differ from one nanoparticle shape to another, but also the 
coordination of the atoms on the available surfaces, lead-
ing to different surface energies for each different mor-
phology, which might play a role in the protein binding. 
A future full understanding of the morphology role on 
nanoparticle-protein interactions and a very detailed char-
acterization of the corona are essential to the achievement 
of the desired effects of the nanoparticles in vivo, opening 
room to future studies that might link the right morphol-
ogy according to the required effect.
Shannahan et  al. [70] characterized citrate-silver 
nanoparticles (24.4  nm, −46.6  mV zeta potential) and 
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PVP-silver nanoparticles (26.6 nm, −35.9 mV zeta poten-
tial) in water or DMEM cell culture medium. A slight 
effect was observed when silver nanoparticles were sus-
pended in DMEM without serum. From the results, it 
was clear that citrate-stabilized silver nanoparticles in 
water exhibited more negative zeta potentials than did 
PVP-stabilized nanoparticles of a similar diameter. Anal-
yses of the composition of the protein coronas for a set 
of four silver nanoparticles, including citrate-stabilized 
and PVP-stabilized colloidal silver (~20 or ~110  nm 
diameter), were accomplished. The silver nanoparti-
cles were incubated in DMEM supplemented with 10 % 
FBS, then washed several times, and the protein corona 
was solubilized and analyzed by label-free LC–MS/MS. 
The silver nanoparticles were found to be associated 
with a common subset of 11 proteins, including albu-
min, apolipoproteins, keratins, and other serum proteins. 
In fact, for the 110  nm citrate- and PVP-stabilized sil-
ver nanoparticles, the results showed binding to 79 and 
85 proteins, respectively, and for the 20 nm citrate- and 
Scheme 1 NP–protein interactions. The process of conjugation of the NP when inserted in biological media takes few minutes in the working 
conditions (I), which evolves to a NP coated with protein in equilibrium with the proteins in the medium (II), then later evolves towards an irrevers-
ible protein corona with proteins that are no longer in equilibrium with their in-solution counterparts (III) (reproduced from ref. Casals et al. [72] by 
permission of Wiley–VCH Verlag GmbH & Co. KGaA, Weinheim)
Fig. 6 Schematic representation of a silver nanocubes surrounded 
by both slowly exchanging and rapidly exchanging proteins in a 
two-layer model (modified from ref. Miclaus et al. [40] by permission 
of ACS Publications)
Fig. 7 SDS–PAGE analysis demonstrate results in which various shapes and concentrations of silver nanoparticles were incubated in FBS, illustrating 
a clear difference in the protein corona composition and evolution trend for different shapes of particles (reproduced from ref. Ashkarran, et al. [1] 
by permission of American Chemical Society)
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PVP-stabilized nanoparticles, the results showed binding 
of 45 and 48 proteins, respectively. The authors suggest 
that this is an indication that surface curvature effects 
are ruling the protein corona formation. Regarding the 
specificity of the silver nanoparticles studied, 19 proteins 
bound only the 20 nm silver nanoparticles (PVP and cit-
rate), whereas 60 bound only the 110 nm silver nanopar-
ticles (PVP and citrate). The authors indicate that these 
different protein profiles may also give a protein corona 
signature that is based on the size and/or surface curva-
ture of the silver nanoparticles. However, it is important 
to point out that the total surface area available related 
to each of the nanoparticles studied (~20 and  ~110  nm 
diameter) are completely different, which might affect 
the amount and composition of proteins binding to the 
nanoparticles. The difference in the total surface area 
available to bind proteins results from normalizing by 
weight the amount of nanoparticles used in the corona 
studies, in which the authors incubated 1  mg of each 
nanoparticle with the media. This highlights the need to 
start considering the total surface area as a parameter to 
be controlled in this type of studies.
Human blood plasma
Silver nanoparticles may supply antimicrobial efficacy 
when used as coatings on several biomedical devices. 
Therefore, it is very important to understand the interac-
tions of silver nanoparticles with blood components (e.g., 
RBCs, WBCs, plasma proteins, etc.) [23, 75]. In human 
plasma, a typical nanoparticle protein corona consists 
of proteins such as HSA, immunoglobulins, fibrinogen, 
apolipoproteins, transferrin, complement proteins, and 
hemoglobin. The adsorption pattern of blood proteins to 
external inorganic surfaces is a functional event in which 
the most abundant proteins (e.g., HSA and fibrinogen) 
may initially be absorbed by the surface and then later 
replaced by other proteins that have a greater binding 
affinity for the surface (i.e., Vroman theory) [76]. How-
ever, there is no universal theory that can be applied 
to all types of nanoparticles when exposed to human 
plasma [77]. Human plasma protein corona formation 
on metallic nanoparticles (i.e., gold and iron) has been 
reported [78, 79]. However, we have not found reports in 
the literature for silver nanoparticles (to the best of our 
knowledge). Recently, using surface-enhanced Raman 
spectroscopy (SERS), interactions of silver nanoparticles 
with normal and cervical cancer human plasma collected 
from patients were reported [80]. In this specific case that 
action of proteins and silver nanoparticles were used as 
markers for differentiation of normal and cancer human 
plasma. The prominent SERS peak is attributed to the 
amide I band of the human serum albumin (HSA) and 
in cancer this band was found to be higher than normal 
plasma, indicating that the elevated relative amount of 
proteins in the α-helix conformation was due to the can-
cer development. In other words, the selective proteins in 
cancer exert a different interaction with silver nanopar-
ticles than normal plasma. These findings point towards 
the importance and role of the medium in the protein-
nanoparticle interactions. Future studies that focus on a 
complete and accurate characterization of the corona and 
subsequently in the comparison of its composition in dif-
ferent disease conditions might give valuable information 
about the key proteins involved in the development and 
progress of certain illnesses.
Human serum albumin (HSA)
A study by Gebauer et  al. [81] showed that the protein 
corona formed by human serum albumin (HSA) on 
citrate-functionalized silver nanoparticles stabilized 
them against agglomeration. One important aspect of 
this research was that agglomeration kinetics can be 
employed to prescribe apparent affinities to describe the 
protein adsorption/desorption equilibrium. Furthermore, 
circular dichroism spectroscopy was used as a comple-
mentary technique to measure affinities for the same 
process. The apparent KD values obtained using both 
approaches were correlated with other published values. 
The protein coronas found around silver nanoparticles in 
these experiments consisted of a monolayer of protein on 
the nanoparticle surfaces, corroborating previous results 
of HSA adsorption to polymer-coated nanoparticles [50].
Chen et  al. [82] studied the interactions between cit-
rate-silver nanoparticles and HSA using several methods, 
including UV–Vis, TEM, and CD measurements, and 
found that silver nanoparticle-HSA binding was medi-
ated by the physical forces of hydrogen bonding, electro-
static interaction, and hydrophobic interaction. In this 
study, the percent of α-helices was reduced, whereas that 
of β-sheets increased in the secondary HSA structures 
after interaction with silver nanoparticles. The authors 
suggested that this was a result of hydrogen bond break-
age between proximal α-helices and configuration of new, 
less ordered hydrogen bonds between the α-helices and 
the citrate coating of the silver nanoparticles. CD meas-
urements indicated that the presence of lipid vesicles 
(i.e., the membrane model) relaxed the conformational 
changes of the proteins induced by the nanoparticles, 
most likely due to the electrostatic repulsion between 
them. Generalized polarization (GP; fluorescence ratio) 
measurements demonstrated that nanoparticles and 
protein coronas interact with lipid vesicles to enhance 
their fluidity. In contrast, free proteins did not exert this 
effect on vesicle conformation. Utilizing these results, the 
authors suggested that in the formation of nanoparticle 
protein coronas, the physical interactions between the 
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nanoparticle core and cell membranes probably did not 
occur easily. The implications of these results together 
with the biological and biochemical mechanisms of 
endocytosis, lipid peroxidation, and enzymatic activity, 
could be an important issue in nanomedicine and nano-
toxicology applications [82].
After a 2-h pre-incubation with proteins (HSA/trans-
ferrin), citrate-silver nanoparticles (20 and 110 nm) were 
studied as they acted on human epidermal keratinocyte 
(HEK) cells, and the cellular uptake showed that for 20 
and 110 nm citrate silver nanoparticles, protein incuba-
tion significantly modulated silver nanoparticle uptake. 
Silver incubation with albumin and IgG, and in a minor 
extension with transferrin, reduced the extent of cel-
lular uptake [81]. Moreover, IgG exposure dramatically 
reduced the 110 nm citrate silver uptake. Similar profiles 
were also found with silver nanoparticles in the mem-
brane fraction with protein incubation in general, sig-
nificantly altering the association of the particle to the 
membrane. Silver nanoparticles, independent of size and 
protein exposure, were found inside the cytoplasmic vac-
uoles of the HEKs.
Figure 8 shows a transmission electron micrograph that 
has captured several 120 nm silica-coated silver nanopar-
ticles in the process of phagocytosis by a HEK cell.
The 20  nm citrate silver nanoparticles bound to albu-
min were highly dispersed and appeared to break down 
or disintegrate within the vacuoles, whereas nanopar-
ticles bound to IgG, transferrin, and the native control 
showed very low agglomeration. However, for 20  nm 
citrate coated silver nanoparticles, protein incubation 
reduced cellular concentrations, and for the 110 nm cit-
rate silver nanoparticles, incubation with IgG signifi-
cantly reduced the uptake of silver nanoparticles. The 
authors stated that this pattern of protein modulation 
of silver nanoparticle uptake was not as important com-
pared with that of different proteins that clearly modify 
silver nanoparticle uptake into HEK. They also discussed 
the cytoplasmic data that showed that nanoparticles 
certainly entered the cellular domain, which brought up 
questions as to how in vitro assays using native nanopar-
ticles could be correlated to what would be expected to 
occur in vivo [83].
In the case of HAS, the incubation significantly mod-
ulated silver nanoparticle uptake independently of the 
nanoparticles sizes. The incubation with albumin and 
IgG, and in a minor extension with transferrin, reduced 
the extent of cellular uptake.
Tubulin (cytoskeletal protein)
In a study with actin and tubulin (cytoskeletal proteins) 
interacting with citrate-silver nanoparticles, both gave 
high standard deviations for the zeta potentials. The 
silver nanoparticles had a diameter of 35.7  nm and a 
zeta potential of −42.5 mV and actin had a diameter of 
2.0  nm and a zeta potential of −28.0  mV, while actin-
silver nanoparticles had a diameter of 39.4 and a zeta 
potential of −36.6  mV. It was suggested that this was 
due to self-aggregation and less extensive polymeriza-
tion. The actin-silver nanoparticles exhibited a smaller 
deviation in zeta potential than the tubulin-silver nano-
particles, indicating that the protein corona from actin-
silver nanoparticles was more homogeneous than the 
tubulin-silver nanoparticles. As discussed previously, the 
secondary structures of actin and tubulin were altered 
after interaction with silver nanoparticles. The α-helices 
of actin showed a 24  % decrease whereas the β-sheets 
showed a 36 % increase upon binding to the silver nano-
particles, and no random coils were observed. For tubu-
lin, a 17  % decrease and 5  % increase in α-helices and 
β-sheets, respectively, was demonstrated. In the latter 
protein, 11 % random coils were found after binding with 
silver nanoparticles. The conformational changes were 
more significant for actin than tubulin, corroborating 
the UV–Vis absorbance measurements and the hyper-
spectral imaging. Other important aspects of this report 
included silver ion release in these types of interactions. 
In the absence of cytoskeletal proteins, silver nanopar-
ticles rapidly released silver ions for the first 4  h, but 
the rate of release subsequently leveled off for a period 
of 72  h (5  % dissolution). In the presence of actin and 
tubulin, however, the release of silver ions progressed at 
a slower pace, where only 1  % dissolution was attained 
during the first few hours (Fig. 9).
Fig. 8 Transmission electron micrograph of an HEK engulfing 120 nm 
silica-coated silver nanoparticles. Arrow denotes silver nanoparticles 
within invagination. Bar 2 µm (reproduced from ref. Monteiro-Riviere 
et al. [81] by permission of Elsevier Ireland Ltd.)
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These data imply that coating silver nanoparticles with 
cytoskeletal proteins physically prevented release of the 
silver ions, and the conformation and physicochemical 
properties of silver nanoparticles were improved by hard-
ened cytoskeletal proteins [84].
Ubiquitin (a structurally conserved protein that regulates 
numerous in eukaryotic cell processes)
Ding et al. [85] used a combination of molecular dynam-
ics simulations and complementary experiments to 
characterize the ubiquitin corona on citrate silver nano-
particles of around 13  nm (Fig.  10). To measure the 
impact of silver nanoparticles on the ubiquitin confor-
mation, the Q-value was studied for all protein residues, 
which is the fraction of native contacts for silver nanopar-
ticles when bound to ubiquitin or unbound. The Q-values 
were close to 1, indicating that both components main-
tained native-like structures. The loop regions between 
the secondary structures had relatively low Q-values. A 
region near the C-terminus of the helix and another close 
to residue 46 in a loop were strongly destabilized upon 
binding with silver nanoparticles. These data were con-
sistent with results from circular dichroism, where the 
helical content was reduced by 27.8 % by the silver nan-
oparticle-bound ubiquitin compared to free ubiquitin. 
These measurements also showed a slight increase in the 
β-sheet content. The authors hypothesized that as a func-
tion of protein concentration on the silver nanoparticle 
surfaces, the increase in β-sheet content could be due to 
the formation of inter-protein hydrogen bonds through 
partially unfolded protein regions.
Hyaluronan‑binding protein
Hyaluronan is a major component of cell-surface glyco-
proteins and the extracellular matrix, surface adsorbed 
hyaluronan-binding proteins may act as “bridges” that 
mediate the interaction of nanoparticles with the cell sur-
face. Recently Walkey et  al. [86] noted that using quan-
titative models (a bioinformatics-inspired approach) to 
predict the biological interactions of nanoparticles that 
they included for the characterization of the blood pro-
tein coronas is the most comprehensive quantitative 
analysis published to date. The model implicated a col-
lection of hyaluronan-binding proteins as mediators of 
silver nanoparticle-cell interactions. They also indicated 
the probability of using this database to develop exact 
relationships that can predict the biological responses 
to nanoparticles and potentially help in uncovering the 
basic nano-bio interaction mechanisms.
Yeast extracted proteins
Eigenheer et al. [87] reported an approach where mass 
spectrometry proteomics was implemented to deter-
mine protein corona populations (from yeast extract) 
and to measure protein enrichment on the surfaces of 
different silver nanoparticle [negative citrate-coated 
particles (10 and 100  nm) and positive branched 
polyethyleneimine coated particles (100  nm)] under 
biologically and environmentally important reac-
tion conditions. BY4 yeast was cultured and the cells 
treated to obtain the protein content. After incuba-
tion of 0.25 mg mL−1 nanoparticles and 0.21 mg mL−1 
soluble yeast protein extract for 16 h, the nanoparticles 
and adsorbed proteins were precipitated, centrifuged 
and washed several times to remove non-associated 
and loosely associated proteins from the nanoparticles. 
Nanoparticle adsorbed proteins were directly digested 
off the nanoparticles (e.g., trypsin) for identification 
of well adsorbed and low abundance corona proteins. 
More than 500 proteins were identified in the sample 
studied, including nanoparticles with associated and 
unassociated proteins. To understand the role of silver 
nanoparticle properties in protein corona formation, 
the protein–nanoparticle interaction was carried out 
with low salt and buffer concentrations. The protein 
coronas of citrate-silver nanoparticles (10 nm, negative) 
were compared to polyethyleneimine-silver nanopar-
ticles (10  nm, positive) and citrate-silver nanoparticles 
(100  nm, negative) to investigate the roles of surface 
charge and size, respectively. The data from the pro-
tein corona concentration experiments clearly indicated 
that the charge on the surface of the silver nanoparticles 
played a greater role in corona formation than did their 
size. The authors presented a Venn diagram to compare 
Fig. 9 Release of silver ions with and without the presence of 
proteins, measured (n = 3) by ICP–MS. Original silver nanoparticles 
(AgNP) concentration: 5 mg L−1. Actin and tubulin concentrations: 
5 mg L−1 (reproduced from ref. Wen et al. [82] by permission of The 
Royal Society of Chemistry)
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the different protein corona populations and found that 
10 and 100  nm (negative) citrate-silver nanoparticles 
were the most similar, with approximately 83 % of pro-
teins (376 proteins) shared across their protein corona 
distributions. Meanwhile, the differences provided 
insight into the importance of nanoparticle properties. 
Notably, approximately 50  % of the proteins (247 pro-
teins) were found within the coronas of all nanoparticles 
studied, which demonstrated that these proteins would 
be found on the nanoparticles independent of their 
surface coating or size and are therefore an important 
group of proteins that must be studied in further detail. 
The authors also suggested that the surface charge, an 
apparent biophysical property of the proteins studied, 
probably regulates binding to silver nanoparticles, as 
shown clearly in Fig.  11. Here, there was an increase 
in the abundance of negatively charged proteins that 
bind to (+) silver nanoparticles compared to the 10 and 
Fig. 10 Interaction between a single ubiquitin and a citrate-coated silver nanoparticles. a TEM images of silver nanoparticles (left panel) and silver 
nanoparticles-ubiquitin coronas (right panel) where the associations of the silver nanoparticles and the proteins (shaded regions) are evident to 
imply their good binding affinity. b UV–vis absorbance of silver nanoparticles, ubiquitin, and silver nanoparticles–ubiquitin, featuring a red-shift 
of the absorbance peaks for silver nanoparticles–ubiquitin and silver nanoparticles alone due to dampened surface plasmon resonance. c Initial 
(t = 0 ns) and final (t = 50 ns) structure of the ubiquitin–citrate–silver nanoparticles complex system. Ubiquitin is represented as cartoons, the side 
chains as lines, and the citrates as sticks. The gray sphere represents the nanoparticle, and the charged atoms on the silver nanoparticles surface 
are shown as blue spheres. The zoom-in view of the final structure indicates the binding between the ubiquitin and a charged silver nanoparticles 
surface atom (modified from Ding et al. [83] by permission of The Royal Society of Chemistry)
Fig. 11 Percent abundance of protein pIs across the six sample 
conditions tested (reproduced from ref. Eigenheer et al. [85] by per-
mission of The Royal Society of Chemistry)
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100  nm (−) silver nanoparticles. In other words, there 
was a two-fold decrease in the anionic proteins bound 
to 10  nm (34  %) and 100  nm (−) silver nanoparticles 
(20  %), compared to (+) silver nanoparticles (71  %). 
These data demonstrated that electrostatics is a deter-
minant factor in the modulation of protein affinity for 
silver nanoparticles. Finally, the authors stated that, at 
the most basic level, all of this information reaffirms 
the importance of ample nanoparticle characterization 
and the reaction conditions when analyzing the protein 
coronas of nanoparticles.
Biological activities related to the protein corona
Antibacterial activity
The antibacterial activities of borate-silver, citrate-sil-
ver and PVP-silver nanoparticles were studied. Borate-
silver nanoparticles were inactive against Salmonella 
when tested in Luria–Bertani  (LB) broth, but were 
efficient against Salmonella in PBS buffer. When anti-
bacterial activity was tested in PBS (no blood, serum 
or plasma present), no activity differences were found 
for the different types of silver nanoparticles. However, 
blood, serum or plasma completely inhibited the activ-
ity of borate-silver nanoparticles but not citrate-silver 
or PVP-silver nanoparticles. The activity of the PVP-
silver nanoparticles was stronger than that of the cit-
rate-silver nanoparticles. Nanoparticle activity against 
S. typhimurium was studied in the presence of mouse 
blood components, whereas for S. typhi, the activity was 
analyzed in the presence of human blood components. 
Serum albumin is the major component of blood; 3  % 
BSA was used to measure the antibacterial effects of the 
silver nanoparticles under study. BSA addition totally 
abolished the antibacterial activity of the borate-silver 
nanoparticles but not that of the citrate- or PVP-silver 
nanoparticles [88].
Citrate- and PVP-silver nanoparticles presented anti-
bacterial properties in LB broth. The authors suggested 
that this might be due to the prevention of interaction of 
silver nanoparticles via the LB components or the inhibi-
tion of agglomeration of these particles.
A murine salmonellosis model was used by the same 
authors to understand the effect of the capping agent on 
the silver nanoparticles. BALB/c mice were infected with 
S. typhimurium (orally/i.v.), and the bacterial burdens in 
the mesenteric lymph nodes, spleen, and liver were stud-
ied. No effect of silver nanoparticles was observed when 
borate-silver nanoparticles (described as uncapped-silver 
nanoparticles) were administered to treat the Salmonella 
infection, whereas citrate- and PVP-silver nanoparticles 
reduced the bacterial burden in different organs; PVP-
silver nanoparticles showed an efficient antibacterial 
effect. Finally, when the borate-silver nanoparticles were 
used, all mice died after the same period as in the con-
trols, whereas oral and i.v. administration of citrate- or 
PVP-silver nanoparticles delayed the death of the mice. 
However, when the silver nanoparticles were all admin-
istered intravenously, the PVP- and citrate-silver nano-
particles protected 60 and 40 % of the mice from death, 
respectively. This difference between oral and i.v. admin-
istration was attributed to the fact that silver nanoparti-
cles from oral administration were excreted through the 
feces. The authors noted that this study was the first to 
show the role of the capping agent in antibacterial activ-
ity under physiological conditions in an animal model 
and also how the efficacy of silver nanoparticles varies 
between PBS and biological fluids [88]. As previously dis-
cussed, not only in in vitro studies but also in vivo anti-
bacterial activity of silver nanoparticles depends on the 
capping agents.
Cytotoxicity
Citrate-silver nanoparticles were found by Shannahan 
et  al. [41] to readily associate and form protein coronas 
with human serum albumin (HSA), bovine serum albumin 
(BSA), and high density lipoprotein (HDL). The accumu-
lation of all protein coronas increased the hydrodynamic 
sizes of the silver nanoparticles. The addition of HSA and 
BSA reduced the dissolution of silver nanoparticles (silver 
ion formation), whereas, for HDL, dissolution increased 
compared with silver nanoparticles in water. The authors 
suggested that this occurred because of a reduction in the 
zeta potential of the HDL-silver nanoparticles compared 
with other samples. Moreover, HDL probably offset citrate 
groups and produced a destabilization of the silver nanopar-
ticles, generating an increase in total dissolution. Circular 
dichroism measurements showed that protein association 
with silver nanoparticles decreased the number of α-helices 
in all protein coronas, but for HDL-silver nanoparticles, 
the number of α-helices increased. For HSA and BSA, this 
increase probably arose from entropy-driven unfolding of 
the protein and the formation of hydrogen bonding between 
the proteins and the silver nanoparticles. However, for HDL, 
this probably did not occur because this material has a high 
lipid content and a high degree of structural complexity. 
Additionally, the number of β-sheets increased in all pro-
teins, and protein turns as well as the quantity of unordered 
proteins were also discussed. An important topic investi-
gated by this research was the role of the protein corona in 
the toxicity induced by silver nanoparticles in two cell types 
that are common targets of nanoparticle exposure, rat lung 
epithelial (RLE) and rat aortic endothelial (RAEC) cells. As 
observed by hyperspectral analysis, the protein coronas on 
the silver nanoparticles were lost after internalization and 
these nanoparticles activated cells by inducing IL-6 mRNA 
expression. Pretreatment with an SR-BI inhibitor (inhibitor 
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of the HDL receptor) diminished the internalization of silver 
nanoparticles both with and without a protein corona, and it 
reduced cytotoxicity and IL-6 mRNA expression. Therefore, 
this study characterized the formation of a protein corona 
on silver nanoparticles and showed its influence on cell acti-
vation and cytotoxicity through cell surface receptors.
In 2014, citrate-silver nanoparticles functionalized 
with three different thioglycosides (glucose-, galactose-, 
and mannose-silver nanoparticles) and thioglycol-silver 
nanoparticles were synthesized by Kennedy et  al. [89]. 
The cytotoxicity of these functionalized silver nanopar-
ticles were tested against a neuron-like cell line (Neuro-
2A) and a hepatocyte cell line (HepG2). The coating was 
clearly important for their toxicity. Glycol-, glucose- 
and citrate-functionalized silver nanoparticles exhib-
ited a similarly high toxicity. However, galactose- and 
mannose-functionalized nanoparticles were significantly 
less toxic towards both cell lines. The formation of pro-
tein carbonyls was analyzed as an indirect mark for the 
oxidative stress induced by nanoparticles because pro-
teins can become carboxylated either as a direct or an 
indirect consequence of reactive oxygen species forma-
tion (Fig. 12).
The authors found a strong correlation between car-
bonyl formation and EC50 values, suggesting that toxic-
ity is predominantly caused by the oxidative stress related 
to ROS formation. However, it is also possible that tox-
icity can arise from different cellular uptake rates. An 
ICP-MS and confocal microscopy experiment showed 
that for both cell lines, the less toxic galactose-function-
alized nanoparticles were taken up more efficiently com-
pared to mannose- or glucose-functionalized particles, 
Fig. 12 Toxicity results in vitro. a EC50 values from MTT assay using silver nanoparticles with different coatings and HepG2 cells; b analogous with 
Neuro-2 cells; c detection of oxidative stress from silver nanoparticles (concentration 5 pM) via formation of protein carbonyls incubated with 
HepG2 cells. d Protein carbonyls were detected at different concentrations (2.5, 5, 10 pM) as (DNP) hydrazone adducts via immunoblots with a DNP 
antibody (reproduced from ref. Kennedy et al. [87] by permission of BioMed Central)
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which was probably due to a galactose-specific receptor 
on the surface of the cells. In other words, higher cell 
internalization does not necessary indicate higher toxic-
ity. The glucose-silver nanoparticles caused the highest 
toxicity and protein carboxylation but not the highest 
cellular uptake, when compared with the other func-
tionalized nanoparticles. A confocal microscopy image 
of the Neuro-2A cells showed that the galactose-silver 
nanoparticles were mainly inside the cytoplasm (e.g., 
inside vesicular structures) but not in the nucleus. For the 
mannose- and glucose-silver nanoparticles, their clus-
ters appeared more evenly dispersed throughout the cell, 
and the intracellular clusters were smaller than those of 
particles with other functional groups. Another aspect 
that these authors discussed was the importance of sur-
face charge for cellular internalization. In these experi-
ments, there was a correlation between the uptake and 
surface charge for mannose, glucose and ethylene glycol 
silver nanoparticles, which are more negatively charged 
and taken up less efficiently. These data were consistent 
with their expectations because the cell lines used were 
also negatively charged owing to their various carbohy-
drate moieties. However, the authors also suggested that 
in addition to special receptors on the cell surface, there 
are also protein coronas on their surfaces from interac-
tion with the culture medium. Zeta potential measure-
ments after incubation showed that all particles exhibited 
similar overall negative charges, confirming the forma-
tion of protein coronas. Presumably, the protein corona 
composition on the surface of the functionalized parti-
cles in this study was expected to be different depend-
ing on particle coating, and the authors clearly found a 
correlation between particle coating, oxidative stress and 
toxicity [89]. It is clear from this study that the formation 
of a protein corona on silver nanoparticles influenced cell 
activation and cytotoxicity through cell surface receptors.
Conclusions
Based on all data related to silver nanoparticles and 
their protein coronas and depending on factors such as 
size, concentration and surface functionalization, unex-
pected interactions with different blood components 
or any biological fluids could interfere with biomedical 
applications, such as antibacterial, antifungal or antican-
cer treatment in  vivo. The scientific community is still 
in the beginning of the exploration of this new subject 
and interestingly, all studies conducted to this end have 
focused on human plasma as the test system for pro-
tein corona studies. Though of extremely importance to 
mimic and study biological interactions with these nano-
materials, the use of this model is still deficient for studies 
with silver nanoparticles. We could see from this review 
that circular dichroism was extensively used to confirm 
the interactions between single proteins and silver nano-
particles, confirming a dynamic type of interaction that 
could lead to protein unfolding. Extending these findings 
to a biological milieu, the changes in the secondary struc-
ture of proteins as a result from protein–nanoparticle 
interaction could lead to different cell responses and acti-
vation processes, which is still in need of further inves-
tigation. Understanding the interaction of these protein 
coronas with cells could lead to understanding of their 
immunotoxicity or its reduction by silver nanoparticles 
capped with protein corona. In some cases, silver nano-
particle cytotoxicity was mitigated, depending on protein 
corona composition. Recently Lee et  al. [43] stated that 
there is limited understanding of the connection between 
the physicochemical properties of any nanoparticle and 
their corresponding effects on physiological systems. We 
agree with this statement in the context of silver nano-
particles. However, depending of the application route, 
many advances for in vivo applications have been made 
by functionalization. We will probably see in vivo appli-
cations of silver nanoparticles in the near future. How-
ever, a major challenge will be to compare data across 
interlaboratory studies, which is found to be difficult so 
far as most of them do not follow same conditions. This 
reveals an urgent need to better control the parameters 
of the experiments as well as to standardize some of 
conditions, e.g. particle concentration, total surface area 
available and biological fluids conditions, thus making 
possible to build a strong and solid database.
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